EAU Guidelines on Urological Infections - Uroweb

1 G. Bonkat (Chair), R. Bartoletti, F. Bruy re, T. Cai, Geerlings, B. K ves, S. Schubert, F. WagenlehnerGuidelines Associates: W. Devlies, J. Horv th, G. Mantica, T. Mezei, A. Pilatz, B. Pradere, R. Veeratterapillay European Association of Urology 2021 UrologicalInfectionsEAU Guidelines onUROLOGICAL Infections - LIMITED UPDATE MARCH 20212 TABLE OF CONTENTS PAGE1. INTRODUCTION 6 Aim and objectives 6 Panel composition 6 Available publications 6 Publication history 62. METHODS 6 Introduction 6 Review 73.

2 THE GUIDELINE 7 Classification 7 Antimicrobial Stewardship 8 Asymptomatic bacteriuria in adults 9 Evidence question 9 Background 9 Epidemiology, aetiology and pathophysiology 9 Diagnostic evaluation 9 Evidence summary 9 Disease management 9 Patients without identified risk factors 9 Patients with ABU and recurrent UTI, otherwise healthy 9 Pregnant women 10 Is treatment of ABU beneficial in pregnant women? 10 Which treatment duration should be applied to treat ABU in pregnancy? 10 Single dose vs.

3 Short course treatment 10 Patients with identified risk-factors 10 Diabetes mellitus 10 ABU in post-menopausal women 11 Elderly institutionalised patients 11 Patients with renal transplants 11 Patients with dysfunctional and/or reconstructed lower urinary tracts 11 Patients with catheters in the urinary tract 11 Patients with ABU subjected to catheter placements/ exchanges 11 Immuno-compromised and severely diseased patients, patients with candiduria 11 Prior to Urological surgery 12 Prior to orthopaedic surgery 12 Pharmacological management 12 Follow-up 12 Summary of evidence and recommendations for the management of ABU 12 Uncomplicated cystitis 13 Introduction 13 Epidemiology.

4 Aetiology and pathophysiology 13 Diagnostic evaluation 13 Clinical diagnosis 13 Differential diagnosis 13 Laboratory diagnosis 13 Summary of evidence and recommendations for the diagnostic evaluation of uncomplicated cystitis 13 Disease management 14 Cystitis in pregnancy 14 Cystitis in men 14 Renal insufficiency 153 Urological Infections - LIMITED UPDATE MARCH 2021 Summary of evidence and recommendations for antimicrobial therapy for uncomplicated cystitis 15 Follow-up 15 Recurrent UTIs 16 Introduction 16 Diagnostic evaluation 16 Disease management and follow-up 16 Behavioural modifications 16 Non-antimicrobial prophylaxis 16 Hormonal replacement 16 Immunoactive prophylaxis 16 Prophylaxis with probiotics (Lactobacillus spp.)

5 16 Prophylaxis with cranberry 16 Prophylaxis with D-mannose 17 Endovesical instillation 17 Antimicrobials for preventing rUTI 17 Continuous low-dose antimicrobial prophylaxis and post- coital prophylaxis 17 Self-diagnosis and self-treatment 17 Summary of evidence and recommendations for the diagnostic evaluation and treatment of rUTIs 17 Uncomplicated pyelonephritis 18 Diagnostic evaluation 18 Clinical diagnosis 18 Differential diagnosis 18 Laboratory diagnosis 18 Imaging diagnosis 18 Summary of evidence and recommendations for the diagnostic evaluation of uncomplicated pyelonephritis 18 Disease management 18 Outpatient treatment 18 Inpatient treatment 19 Summary of evidence and recommendations for the treatment of uncomplicated pyelonephritis 19 Follow-up 20 Complicated UTIs 20 Introduction 20 Diagnostic evaluation 21 Clinical presentation 21 Urine culture 21 Microbiology (spectrum and antimicrobial resistance)

6 21 General principles of cUTI treatment 21 Choice of antimicrobials 21 Duration of antimicrobial therapy 22 Summary of evidence and recommendations for the treatment of complicated UTIs 22 catheter -associated UTIs 23 Introduction 23 Epidemiology, aetiology and pathophysiology 23 Diagnostic evaluation 23 Clinical diagnosis 23 Laboratory diagnosis 23 Summary of evidence table and recommendations for diagnostic evaluation of CA-UTI 23 Disease management 24 Limiting catheterisation and appropriate catheter discontinuation 24 Urethral cleaning and chlorhexidine bathing 24 alternatives to indwelling urethral catheterisation 24 Impregnated or coated catheters 24 Antibiotic prophylaxis for catheter removal or insertion 24 Urological Infections - LIMITED UPDATE MARCH 20214 Antibiotic prophylaxis for intermittent

7 Self-catheterisation (ISC) 25 Antimicrobial treatment for suspected CAUTI 25 Recommendations for disease management and prevention of CA-UTI 25 Urosepsis 26 Introduction 26 Epidemiology, aetiology and pathophysiology 26 Diagnostic evaluation 27 Physiology and biochemical markers 27 Cytokines as markers of the septic response 27 Biochemical markers 27 Disease management 27 Prevention 27 Preventive measures of proven or probable efficacy 28 Appropriate peri-operative antimicrobial prophylaxis 28 Treatment 28 Antimicrobial therapy 28 Source control 28 Adjunctive measures 28 Summary of evidence and recommendations for the diagnosis and treatment of urosepsis 29 Urethritis 29

8 Introduction 29 Epidemiology, aetiology and pathogenesis 29 Evidence Questions 30 Evidence Summary 30 Diagnostic evaluation 30 Disease management 30 Gonococcal urethritis 31 Non-gonococcal urethritis 31 Follow-up 31 Summary of evidence and recommendations for the diagnostic evaluation and antimicrobial treatment of urethritis 32 Bacterial Prostatitis 33 Introduction 33 Evidence Question 34 Evidence Summary 34 Epidemiology, aetiology and pathogenesis 34 Diagnostic evaluation 34 History and symptoms 34 Symptom questionnaires 35 Clinical findings 35 Urine cultures and expressed prostatic secretion 35 Prostate biopsy 35 Other tests 35 Additional investigations 35 Ejaculate analysis 35 First-void urine sample 35 Prostate specific antigen (PSA)

9 35 Summary of evidence and recommendations for the diagnosis of bacterial prostatitis 36 Disease management 36 Antimicrobials 36 Intraprostatic injection of antimicrobials 36 Combined treatments 36 Drainage and surgery 37 Summary of evidence and recommendations for the disease management of bacterial prostatitis 37 Follow-up 37 Acute Infective Epididymitis 385 Urological Infections - LIMITED UPDATE MARCH 2021 Evidence question 38 Epidemiology, Aetiology and Pathophysiology 38 Diagnostic Evaluation 38 Disease Management 38 Evidence Summary 38 Screening 39 Summary of evidence and recommendations for the diagnosis and treatment of acute infective epididymitis 39 Fournier s Gangrene (Necrotising fasciitis of the perineum and external genitalia)

10 40 Evidence questions 40 Epidemiology, Aetiology and Pathophysiology 40 Diagnostic Evaluation 40 Disease Management 40 Evidence Summary 41 Summary of evidence and recommendations for the disease management of Fournier s Gangrene 41 Management of Human papilloma virus in men 42 Epidemiology 42 Risk factors 42 Transmission 42 Clearance 43 Diagnosis 43 Treatment of HPV related diseases 43 Treatments suitable for self-application 43 Physician-administered treatment 43 Summary of evidence and recommendations for the treatment of anogenital warts 43